{"DataElement":{"publicId":"7588592","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation Performed Reason","preferredDefinition":"Question to indicate reason hematopoietic stem cell transplantation performed.","longName":"HSCT_RSN","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"2644275","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation Performed","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._Executed and carried through to completion.","longName":"HSCT_PRFRMD","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2531883","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):The grafting of tissues from one individual to another or place to place within a single individual.","longName":"C12551:C15342","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2092946C-8392-20BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-24","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-10-24","modifiedBy":"ONEDATA","dateModified":"2006-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"313D3BAF-61D8-6B29-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-31","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-05-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7588589","version":"1","preferredName":"Hematopoietic Cell Transplantation Reason","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._An explanation of the cause of some phenomenon or action.","longName":"7588589v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC82E5ED-C8A5-0625-E053-4EBD850AF3EC","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ONEDATA","dateModified":"2021-03-01","deletedIndicator":"No"},{"value":"Subsequent relapse","valueDescription":"Subsequent Relapse","ValueMeaning":{"publicId":"6333654","version":"1","preferredName":"Subsequent Relapse","longName":"6333654","preferredDefinition":"The reemergence of a disorder as diagnosed by clinical and/or laboratory evidence following two or more documented periods of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subsequent Relapse","conceptCode":"C123400","definition":"The reemergence of a disorder as diagnosed by clinical and/or laboratory evidence following two or more documented periods of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E1595C7-3690-54C2-E053-F662850AA257","latestVersionIndicator":"Yes","beginDate":"2018-06-07","endDate":null,"createdBy":"HAMMA","dateCreated":"2018-06-07","modifiedBy":"ONEDATA","dateModified":"2018-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC82E5ED-C8B9-0625-E053-4EBD850AF3EC","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ONEDATA","dateModified":"2021-03-01","deletedIndicator":"No"},{"value":"Planned post-CAR T-cell therapy","valueDescription":"Chimeric Antigen Receptor Post Therapeutic Procedure","ValueMeaning":{"publicId":"7588590","version":"1","preferredName":"Chimeric Antigen Receptor Post Therapeutic Procedure","longName":"7588590","preferredDefinition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.: Happening at a time subsequent to a reference time; later in time or order.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chimeric Antigen Receptor","conceptCode":"C126108","definition":"A cell-surface receptor that has been engineered to combine novel features and specificities from various sources in order to enhance its antigen specificity. Engineered T-cells or B-cells will produce the specialized receptor that will be capable of binding to an epitope on its target cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC82E5ED-C8C7-0625-E053-4EBD850AF3EC","latestVersionIndicator":"Yes","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ONEDATA","dateModified":"2021-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC82E5ED-C8E0-0625-E053-4EBD850AF3EC","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ONEDATA","dateModified":"2021-03-01","deletedIndicator":"No"},{"value":"Loss of B-cell aplasia","valueDescription":"Loss B-Cell Aplasia","ValueMeaning":{"publicId":"7588591","version":"1","preferredName":"Loss B-Cell Aplasia","longName":"7588591","preferredDefinition":"A gradual decline in amount or activity.: A condition characterized by extremely low B-cell counts. It occurs when anti-CD19 CAR T-cells attack and kill CD19-expressing B-lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"B-Cell Aplasia","conceptCode":"C162941","definition":"A condition characterized by extremely low B-cell counts. It occurs when anti-CD19 CAR T-cells attack and kill CD19-expressing B-lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC82E5ED-C8ED-0625-E053-4EBD850AF3EC","latestVersionIndicator":"Yes","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ONEDATA","dateModified":"2021-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC82E5ED-C906-0625-E053-4EBD850AF3EC","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ONEDATA","dateModified":"2021-03-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2842596","version":"1","preferredName":"Outcome of Therapy","preferredDefinition":"The result of therapy for a given disease or condition in a patient or group of patients.","longName":"C18919 ","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63D982FA-DFBF-58C7-E040-BB89AD433E84","latestVersionIndicator":"Yes","beginDate":"2009-02-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-02-26","modifiedBy":"CURTIST","dateModified":"2009-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7588588","version":"1","preferredName":"Hematopoietic Cell Transplantation Reason","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.:An explanation of the cause of some phenomenon or action.","longName":"C15431:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC82E5ED-C880-0625-E053-4EBD850AF3EC","latestVersionIndicator":"Yes","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ONEDATA","dateModified":"2021-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC82E5ED-C891-0625-E053-4EBD850AF3EC","latestVersionIndicator":"Yes","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"ARCHERJ","dateModified":"2021-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Why was hematopoietic stem ce","type":"Preferred Question Text","description":"Why was hematopoietic stem cell transplantation performed?","url":null,"context":"COG"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"Indication for HSCT:","url":null,"context":"COG"},{"name":"COG CRF Text 02","type":"Alternate Question Text","description":"Indication for post-CAR T-cell therapy HSCT:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC82E925-E31F-1A1E-E053-4EBD850A8898","latestVersionIndicator":"Yes","beginDate":"2021-03-01","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-03-01","modifiedBy":"MAESKEB","dateModified":"2021-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}